Advocates say since the ACT decriminalised "personal use" amounts of some illicit drugs, the territory has seen a shift ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

J.D. Mowery, Bora, says tariffs localize biopharma supply chains, the "biotech freeze" mandates robust data, and AI rapidly ...

WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...

Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.

Hanmi Pharmaceutical, the core business subsidiary of Hanmi Science, unveiled a range of next-generation modality research achievements at a ...

Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...

Q3 2025 Earnings Call Transcript October 29, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.6, ...

The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, limit ...

Q3 2025 net product revenue for ZORYVE® (roflumilast) was $99.2 million, a 122% increase compared to Q3 of 2024, and a 22% increase compared to ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

At CDMI 2025, an expert discussed the challenges and potential solutions for adopting digital solutions in clinical trials.